Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
Dr. Dereck Mush, MD, MBA
What they do
Onvaro was announced on November 4, 2026 through the combination of Sapphiros and binx health. Its point-of-need diagnostics portfolio includes binx io, with a reported installed base of more than 1,000 instruments. Mike Karsonovich is CEO and Namal Nawana is lead director. No transaction value is disclosed here.
People in this update
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Point-of-need diagnostics
- Product type
- Diagnostics
- Stage
- Headquarters
- Not disclosed
- Region
- Founded
- 2026
- Total funding
- Undisclosed
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Decentralizing Syndromic PCR: The Point-of-Care Molecular Margin War
Dr. Dereck Mush, MD, MBA
The AI ECG Cardiology Market After Queen of Hearts: Who the De Novo Clearance Actually Benefits
Dr. Dereck Mush, MD, MBA